PICK A TIME SLOT
₹ Price not available
Book an appointment for Consultation
₹ Price not available
You will receive an SMS with a verification code on this number.
Are you new to hospital ?
We have sent you an OTP on
Resend OTP
Did not receive OTP? You can request for another OTP. Click on Resend OTP
Go Back
Your appointment is
confirmed.
The details will be shared via Email & SMS
Note :Temporary visitor restriction, only one attendant is permitted with the patient. Your cooperation is solicited.
-
-
-
-
-
-
The main area of interest is Gynaecologic Oncology surgeries, including pelvic, and upper abdominal surgeries, peritonectomies, and radical pelvic floor clearances in Ovarian and cervical Cancers. Laparoscopic pelvic and retroperitoneal nodal clearances in Endometrial cancers, including sentinel lymph nodal biopsies and surgeries involving cancer vulva.
Dr. Rahul Roy Chowdhury is a Clinician scientist and has participated in sponsored and investigator-initiated trials, including a practise-changing trial in advanced cervical cancer. Dr. Chowdhuri has been invited to Chittagong Medical College to act as resource person in training consultants in Gynecological Oncologic surgery and conduct Multidisciplinary Tumour Boards.
- Specialising in gynaecological oncology, focusing on the diagnosis and treatment of gynaecological cancers.
- Expertise in Pelvic and Upper Abdominal Surgeries for the management of various gynaecological and gynae-oncological conditions.
- Proficiency in performing Peritonectomies, a surgical procedure involving the removal of the peritoneum lining.
- Skilled in conducting Laparoscopic Procedures tailored for the management of endometrial cancers, ensuring precise and minimally invasive treatment options.
- Association of Gynecologic Oncologists of India (AGOI)
- Fellowship from the Royal College of Obstetricians and Gynaecologists (FRCOG)
- Indian Society of Clinical Oncology and Cancer Physicians (ISCCP)
- Founding Member of Kolkata Gyneoncology Trials and Translational Research Group (KolGO Trg)
- English
- Bengali
- Hindi
- Local mentor for the Country Training of International Gynac Cancer Society Fellowship
- Invited delegate to the 1st Endometrial Endometrial Cancer Consensus Conference for Clinical Research (ECCC-CR) on November 2nd and 3rd, 2023 in Seoul, Korea. LMIC (India, Nepal, Bangladesh) representative for Endometrial Cancer Consensus meeting on standards in Research on Endometrial Cancer
- Ghosh DD, Chowdhury R R, Dutta R, Mukhopadhyay I, Mukhopadhyay A, Roychoudhury S. In-silico analysis of TCGA data showing multiple POLE-like favourable subgroups overlapping with TP53 mutated endometrial cancer: Implications for clinical practice in low and middle-income countries. https://doi.org/10.1016/j.gore.2023.101209
- Mandal P, Bhattacharjee B, Sen S, Bhattacharya A, Saha SS, Chowdhury RR, Mondal NR, Chakrabarty B, Chatterjee T, Roy S, Sengupta S. Predominance of genomically defined A lineage of HPV16 over D lineage in Indian patients from eastern India with squamous cell carcinoma of the cervix in association with distinct oncogenic phenotypes. Transl Oncol. 2021 Oct 27;15(1):101256. doi: 10.1016/j.tranon.2021.101256. Epub ahead of print. PMID: 34717279; PMCID: PMC8564679.
- Kurtz JE, Gebski V, Sukhin V, Carey M, Kong I, Glasspool RM, Berek JS, de Paiva Batista M, Hall M, Kim JW, Yeoshoua E, Fujiwara N, Nam BH, Polleis S, Lee JY, Strojna A, Farrelly L, Schwameis R, Fossati R, Darlington AS, Lai CH, Wright AA, Rosenblat O, Harter P, Roxburgh P, Chowdhury RR, Chang TC, Paoletti X, Friedlander M; Gynecologic Cancer InterGroup (GCIG) symptom benefit committee. Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee. Gynecol Oncol. 2021 May;161(2):502-507. doi: 10.1016/j.ygyno.2021.02.018. Epub 2021 Feb 19. PMID: 33612336.
- Poster presentation
- Mukhopadhyay A, Ghosh T, Bhattacharjee D, Chakraborty D, Gupta , Roychowdhury I, Chatterjee P, Vemekar M, Chowdhury RR, Intermittent PARP Inhibitor Regimen In Ovarian Cancer (IPIROC): Origin and Feasibility Of Implementing A Proof –Of –Concept Exploratory Study.18 October 2023 IGCS Abstracts.
Overview
Field of Expertise
Fellowship & Membership
Languages Spoken
Awards & Achievements
Talks & Publications
- Association of Gynecologic Oncologists of India (AGOI)
- Fellowship from the Royal College of Obstetricians and Gynaecologists (FRCOG)
- Indian Society of Clinical Oncology and Cancer Physicians (ISCCP)
- Founding Member of Kolkata Gyneoncology Trials and Translational Research Group (KolGO Trg)
The main area of interest is Gynaecologic Oncology surgeries, including pelvic, and upper abdominal surgeries, peritonectomies, and radical pelvic floor clearances in Ovarian and cervical Cancers. Laparoscopic pelvic and retroperitoneal nodal clearances in Endometrial cancers, including sentinel lymph nodal biopsies and surgeries involving cancer vulva.
Dr. Rahul Roy Chowdhury is a Clinician scientist and has participated in sponsored and investigator-initiated trials, including a practise-changing trial in advanced cervical cancer. Dr. Chowdhuri has been invited to Chittagong Medical College to act as resource person in training consultants in Gynecological Oncologic surgery and conduct Multidisciplinary Tumour Boards.
- Specialising in gynaecological oncology, focusing on the diagnosis and treatment of gynaecological cancers.
- Expertise in Pelvic and Upper Abdominal Surgeries for the management of various gynaecological and gynae-oncological conditions.
- Proficiency in performing Peritonectomies, a surgical procedure involving the removal of the peritoneum lining.
- Skilled in conducting Laparoscopic Procedures tailored for the management of endometrial cancers, ensuring precise and minimally invasive treatment options.
- English
- Bengali
- Hindi
- Local mentor for the Country Training of International Gynac Cancer Society Fellowship
- Invited delegate to the 1st Endometrial Endometrial Cancer Consensus Conference for Clinical Research (ECCC-CR) on November 2nd and 3rd, 2023 in Seoul, Korea. LMIC (India, Nepal, Bangladesh) representative for Endometrial Cancer Consensus meeting on standards in Research on Endometrial Cancer
- Ghosh DD, Chowdhury R R, Dutta R, Mukhopadhyay I, Mukhopadhyay A, Roychoudhury S. In-silico analysis of TCGA data showing multiple POLE-like favourable subgroups overlapping with TP53 mutated endometrial cancer: Implications for clinical practice in low and middle-income countries. https://doi.org/10.1016/j.gore.2023.101209
- Mandal P, Bhattacharjee B, Sen S, Bhattacharya A, Saha SS, Chowdhury RR, Mondal NR, Chakrabarty B, Chatterjee T, Roy S, Sengupta S. Predominance of genomically defined A lineage of HPV16 over D lineage in Indian patients from eastern India with squamous cell carcinoma of the cervix in association with distinct oncogenic phenotypes. Transl Oncol. 2021 Oct 27;15(1):101256. doi: 10.1016/j.tranon.2021.101256. Epub ahead of print. PMID: 34717279; PMCID: PMC8564679.
- Kurtz JE, Gebski V, Sukhin V, Carey M, Kong I, Glasspool RM, Berek JS, de Paiva Batista M, Hall M, Kim JW, Yeoshoua E, Fujiwara N, Nam BH, Polleis S, Lee JY, Strojna A, Farrelly L, Schwameis R, Fossati R, Darlington AS, Lai CH, Wright AA, Rosenblat O, Harter P, Roxburgh P, Chowdhury RR, Chang TC, Paoletti X, Friedlander M; Gynecologic Cancer InterGroup (GCIG) symptom benefit committee. Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee. Gynecol Oncol. 2021 May;161(2):502-507. doi: 10.1016/j.ygyno.2021.02.018. Epub 2021 Feb 19. PMID: 33612336.
- Poster presentation
- Mukhopadhyay A, Ghosh T, Bhattacharjee D, Chakraborty D, Gupta , Roychowdhury I, Chatterjee P, Vemekar M, Chowdhury RR, Intermittent PARP Inhibitor Regimen In Ovarian Cancer (IPIROC): Origin and Feasibility Of Implementing A Proof –Of –Concept Exploratory Study.18 October 2023 IGCS Abstracts.
Fellowship & Membership
Overview
Field of Expertise
Languages Spoken
Awards & Achievements
Talks & Publications
- English
- Bengali
- Hindi
The main area of interest is Gynaecologic Oncology surgeries, including pelvic, and upper abdominal surgeries, peritonectomies, and radical pelvic floor clearances in Ovarian and cervical Cancers. Laparoscopic pelvic and retroperitoneal nodal clearances in Endometrial cancers, including sentinel lymph nodal biopsies and surgeries involving cancer vulva.
Dr. Rahul Roy Chowdhury is a Clinician scientist and has participated in sponsored and investigator-initiated trials, including a practise-changing trial in advanced cervical cancer. Dr. Chowdhuri has been invited to Chittagong Medical College to act as resource person in training consultants in Gynecological Oncologic surgery and conduct Multidisciplinary Tumour Boards.
- Association of Gynecologic Oncologists of India (AGOI)
- Fellowship from the Royal College of Obstetricians and Gynaecologists (FRCOG)
- Indian Society of Clinical Oncology and Cancer Physicians (ISCCP)
- Founding Member of Kolkata Gyneoncology Trials and Translational Research Group (KolGO Trg)
- Specialising in gynaecological oncology, focusing on the diagnosis and treatment of gynaecological cancers.
- Expertise in Pelvic and Upper Abdominal Surgeries for the management of various gynaecological and gynae-oncological conditions.
- Proficiency in performing Peritonectomies, a surgical procedure involving the removal of the peritoneum lining.
- Skilled in conducting Laparoscopic Procedures tailored for the management of endometrial cancers, ensuring precise and minimally invasive treatment options.
- Local mentor for the Country Training of International Gynac Cancer Society Fellowship
- Invited delegate to the 1st Endometrial Endometrial Cancer Consensus Conference for Clinical Research (ECCC-CR) on November 2nd and 3rd, 2023 in Seoul, Korea. LMIC (India, Nepal, Bangladesh) representative for Endometrial Cancer Consensus meeting on standards in Research on Endometrial Cancer
- Ghosh DD, Chowdhury R R, Dutta R, Mukhopadhyay I, Mukhopadhyay A, Roychoudhury S. In-silico analysis of TCGA data showing multiple POLE-like favourable subgroups overlapping with TP53 mutated endometrial cancer: Implications for clinical practice in low and middle-income countries. https://doi.org/10.1016/j.gore.2023.101209
- Mandal P, Bhattacharjee B, Sen S, Bhattacharya A, Saha SS, Chowdhury RR, Mondal NR, Chakrabarty B, Chatterjee T, Roy S, Sengupta S. Predominance of genomically defined A lineage of HPV16 over D lineage in Indian patients from eastern India with squamous cell carcinoma of the cervix in association with distinct oncogenic phenotypes. Transl Oncol. 2021 Oct 27;15(1):101256. doi: 10.1016/j.tranon.2021.101256. Epub ahead of print. PMID: 34717279; PMCID: PMC8564679.
- Kurtz JE, Gebski V, Sukhin V, Carey M, Kong I, Glasspool RM, Berek JS, de Paiva Batista M, Hall M, Kim JW, Yeoshoua E, Fujiwara N, Nam BH, Polleis S, Lee JY, Strojna A, Farrelly L, Schwameis R, Fossati R, Darlington AS, Lai CH, Wright AA, Rosenblat O, Harter P, Roxburgh P, Chowdhury RR, Chang TC, Paoletti X, Friedlander M; Gynecologic Cancer InterGroup (GCIG) symptom benefit committee. Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee. Gynecol Oncol. 2021 May;161(2):502-507. doi: 10.1016/j.ygyno.2021.02.018. Epub 2021 Feb 19. PMID: 33612336.
- Poster presentation
- Mukhopadhyay A, Ghosh T, Bhattacharjee D, Chakraborty D, Gupta , Roychowdhury I, Chatterjee P, Vemekar M, Chowdhury RR, Intermittent PARP Inhibitor Regimen In Ovarian Cancer (IPIROC): Origin and Feasibility Of Implementing A Proof –Of –Concept Exploratory Study.18 October 2023 IGCS Abstracts.
Languages Spoken
Overview
Fellowship & Membership
Field of Expertise
Awards & Achievements
Talks & Publications
- Specialising in gynaecological oncology, focusing on the diagnosis and treatment of gynaecological cancers.
- Expertise in Pelvic and Upper Abdominal Surgeries for the management of various gynaecological and gynae-oncological conditions.
- Proficiency in performing Peritonectomies, a surgical procedure involving the removal of the peritoneum lining.
- Skilled in conducting Laparoscopic Procedures tailored for the management of endometrial cancers, ensuring precise and minimally invasive treatment options.
- Association of Gynecologic Oncologists of India (AGOI)
- Fellowship from the Royal College of Obstetricians and Gynaecologists (FRCOG)
- Indian Society of Clinical Oncology and Cancer Physicians (ISCCP)
- Founding Member of Kolkata Gyneoncology Trials and Translational Research Group (KolGO Trg)
- English
- Bengali
- Hindi
- Local mentor for the Country Training of International Gynac Cancer Society Fellowship
- Invited delegate to the 1st Endometrial Endometrial Cancer Consensus Conference for Clinical Research (ECCC-CR) on November 2nd and 3rd, 2023 in Seoul, Korea. LMIC (India, Nepal, Bangladesh) representative for Endometrial Cancer Consensus meeting on standards in Research on Endometrial Cancer
- Ghosh DD, Chowdhury R R, Dutta R, Mukhopadhyay I, Mukhopadhyay A, Roychoudhury S. In-silico analysis of TCGA data showing multiple POLE-like favourable subgroups overlapping with TP53 mutated endometrial cancer: Implications for clinical practice in low and middle-income countries. https://doi.org/10.1016/j.gore.2023.101209
- Mandal P, Bhattacharjee B, Sen S, Bhattacharya A, Saha SS, Chowdhury RR, Mondal NR, Chakrabarty B, Chatterjee T, Roy S, Sengupta S. Predominance of genomically defined A lineage of HPV16 over D lineage in Indian patients from eastern India with squamous cell carcinoma of the cervix in association with distinct oncogenic phenotypes. Transl Oncol. 2021 Oct 27;15(1):101256. doi: 10.1016/j.tranon.2021.101256. Epub ahead of print. PMID: 34717279; PMCID: PMC8564679.
- Kurtz JE, Gebski V, Sukhin V, Carey M, Kong I, Glasspool RM, Berek JS, de Paiva Batista M, Hall M, Kim JW, Yeoshoua E, Fujiwara N, Nam BH, Polleis S, Lee JY, Strojna A, Farrelly L, Schwameis R, Fossati R, Darlington AS, Lai CH, Wright AA, Rosenblat O, Harter P, Roxburgh P, Chowdhury RR, Chang TC, Paoletti X, Friedlander M; Gynecologic Cancer InterGroup (GCIG) symptom benefit committee. Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee. Gynecol Oncol. 2021 May;161(2):502-507. doi: 10.1016/j.ygyno.2021.02.018. Epub 2021 Feb 19. PMID: 33612336.
- Poster presentation
- Mukhopadhyay A, Ghosh T, Bhattacharjee D, Chakraborty D, Gupta , Roychowdhury I, Chatterjee P, Vemekar M, Chowdhury RR, Intermittent PARP Inhibitor Regimen In Ovarian Cancer (IPIROC): Origin and Feasibility Of Implementing A Proof –Of –Concept Exploratory Study.18 October 2023 IGCS Abstracts.
The main area of interest is Gynaecologic Oncology surgeries, including pelvic, and upper abdominal surgeries, peritonectomies, and radical pelvic floor clearances in Ovarian and cervical Cancers. Laparoscopic pelvic and retroperitoneal nodal clearances in Endometrial cancers, including sentinel lymph nodal biopsies and surgeries involving cancer vulva.
Dr. Rahul Roy Chowdhury is a Clinician scientist and has participated in sponsored and investigator-initiated trials, including a practise-changing trial in advanced cervical cancer. Dr. Chowdhuri has been invited to Chittagong Medical College to act as resource person in training consultants in Gynecological Oncologic surgery and conduct Multidisciplinary Tumour Boards.
Field of Expertise
Fellowship & Membership
Languages Spoken
Awards & Achievements
Talks & Publications
Overview
- Local mentor for the Country Training of International Gynac Cancer Society Fellowship
- Invited delegate to the 1st Endometrial Endometrial Cancer Consensus Conference for Clinical Research (ECCC-CR) on November 2nd and 3rd, 2023 in Seoul, Korea. LMIC (India, Nepal, Bangladesh) representative for Endometrial Cancer Consensus meeting on standards in Research on Endometrial Cancer
- Association of Gynecologic Oncologists of India (AGOI)
- Fellowship from the Royal College of Obstetricians and Gynaecologists (FRCOG)
- Indian Society of Clinical Oncology and Cancer Physicians (ISCCP)
- Founding Member of Kolkata Gyneoncology Trials and Translational Research Group (KolGO Trg)
- Specialising in gynaecological oncology, focusing on the diagnosis and treatment of gynaecological cancers.
- Expertise in Pelvic and Upper Abdominal Surgeries for the management of various gynaecological and gynae-oncological conditions.
- Proficiency in performing Peritonectomies, a surgical procedure involving the removal of the peritoneum lining.
- Skilled in conducting Laparoscopic Procedures tailored for the management of endometrial cancers, ensuring precise and minimally invasive treatment options.
- English
- Bengali
- Hindi
- Ghosh DD, Chowdhury R R, Dutta R, Mukhopadhyay I, Mukhopadhyay A, Roychoudhury S. In-silico analysis of TCGA data showing multiple POLE-like favourable subgroups overlapping with TP53 mutated endometrial cancer: Implications for clinical practice in low and middle-income countries. https://doi.org/10.1016/j.gore.2023.101209
- Mandal P, Bhattacharjee B, Sen S, Bhattacharya A, Saha SS, Chowdhury RR, Mondal NR, Chakrabarty B, Chatterjee T, Roy S, Sengupta S. Predominance of genomically defined A lineage of HPV16 over D lineage in Indian patients from eastern India with squamous cell carcinoma of the cervix in association with distinct oncogenic phenotypes. Transl Oncol. 2021 Oct 27;15(1):101256. doi: 10.1016/j.tranon.2021.101256. Epub ahead of print. PMID: 34717279; PMCID: PMC8564679.
- Kurtz JE, Gebski V, Sukhin V, Carey M, Kong I, Glasspool RM, Berek JS, de Paiva Batista M, Hall M, Kim JW, Yeoshoua E, Fujiwara N, Nam BH, Polleis S, Lee JY, Strojna A, Farrelly L, Schwameis R, Fossati R, Darlington AS, Lai CH, Wright AA, Rosenblat O, Harter P, Roxburgh P, Chowdhury RR, Chang TC, Paoletti X, Friedlander M; Gynecologic Cancer InterGroup (GCIG) symptom benefit committee. Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee. Gynecol Oncol. 2021 May;161(2):502-507. doi: 10.1016/j.ygyno.2021.02.018. Epub 2021 Feb 19. PMID: 33612336.
- Poster presentation
- Mukhopadhyay A, Ghosh T, Bhattacharjee D, Chakraborty D, Gupta , Roychowdhury I, Chatterjee P, Vemekar M, Chowdhury RR, Intermittent PARP Inhibitor Regimen In Ovarian Cancer (IPIROC): Origin and Feasibility Of Implementing A Proof –Of –Concept Exploratory Study.18 October 2023 IGCS Abstracts.
The main area of interest is Gynaecologic Oncology surgeries, including pelvic, and upper abdominal surgeries, peritonectomies, and radical pelvic floor clearances in Ovarian and cervical Cancers. Laparoscopic pelvic and retroperitoneal nodal clearances in Endometrial cancers, including sentinel lymph nodal biopsies and surgeries involving cancer vulva.
Dr. Rahul Roy Chowdhury is a Clinician scientist and has participated in sponsored and investigator-initiated trials, including a practise-changing trial in advanced cervical cancer. Dr. Chowdhuri has been invited to Chittagong Medical College to act as resource person in training consultants in Gynecological Oncologic surgery and conduct Multidisciplinary Tumour Boards.
Awards & Achievements
Fellowship & Membership
Field of Expertise
Languages Spoken
Talks & Publications
Overview
- Ghosh DD, Chowdhury R R, Dutta R, Mukhopadhyay I, Mukhopadhyay A, Roychoudhury S. In-silico analysis of TCGA data showing multiple POLE-like favourable subgroups overlapping with TP53 mutated endometrial cancer: Implications for clinical practice in low and middle-income countries. https://doi.org/10.1016/j.gore.2023.101209
- Mandal P, Bhattacharjee B, Sen S, Bhattacharya A, Saha SS, Chowdhury RR, Mondal NR, Chakrabarty B, Chatterjee T, Roy S, Sengupta S. Predominance of genomically defined A lineage of HPV16 over D lineage in Indian patients from eastern India with squamous cell carcinoma of the cervix in association with distinct oncogenic phenotypes. Transl Oncol. 2021 Oct 27;15(1):101256. doi: 10.1016/j.tranon.2021.101256. Epub ahead of print. PMID: 34717279; PMCID: PMC8564679.
- Kurtz JE, Gebski V, Sukhin V, Carey M, Kong I, Glasspool RM, Berek JS, de Paiva Batista M, Hall M, Kim JW, Yeoshoua E, Fujiwara N, Nam BH, Polleis S, Lee JY, Strojna A, Farrelly L, Schwameis R, Fossati R, Darlington AS, Lai CH, Wright AA, Rosenblat O, Harter P, Roxburgh P, Chowdhury RR, Chang TC, Paoletti X, Friedlander M; Gynecologic Cancer InterGroup (GCIG) symptom benefit committee. Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee. Gynecol Oncol. 2021 May;161(2):502-507. doi: 10.1016/j.ygyno.2021.02.018. Epub 2021 Feb 19. PMID: 33612336.
- Poster presentation
- Mukhopadhyay A, Ghosh T, Bhattacharjee D, Chakraborty D, Gupta , Roychowdhury I, Chatterjee P, Vemekar M, Chowdhury RR, Intermittent PARP Inhibitor Regimen In Ovarian Cancer (IPIROC): Origin and Feasibility Of Implementing A Proof –Of –Concept Exploratory Study.18 October 2023 IGCS Abstracts.
The main area of interest is Gynaecologic Oncology surgeries, including pelvic, and upper abdominal surgeries, peritonectomies, and radical pelvic floor clearances in Ovarian and cervical Cancers. Laparoscopic pelvic and retroperitoneal nodal clearances in Endometrial cancers, including sentinel lymph nodal biopsies and surgeries involving cancer vulva.
Dr. Rahul Roy Chowdhury is a Clinician scientist and has participated in sponsored and investigator-initiated trials, including a practise-changing trial in advanced cervical cancer. Dr. Chowdhuri has been invited to Chittagong Medical College to act as resource person in training consultants in Gynecological Oncologic surgery and conduct Multidisciplinary Tumour Boards.
- Association of Gynecologic Oncologists of India (AGOI)
- Fellowship from the Royal College of Obstetricians and Gynaecologists (FRCOG)
- Indian Society of Clinical Oncology and Cancer Physicians (ISCCP)
- Founding Member of Kolkata Gyneoncology Trials and Translational Research Group (KolGO Trg)
- Specialising in gynaecological oncology, focusing on the diagnosis and treatment of gynaecological cancers.
- Expertise in Pelvic and Upper Abdominal Surgeries for the management of various gynaecological and gynae-oncological conditions.
- Proficiency in performing Peritonectomies, a surgical procedure involving the removal of the peritoneum lining.
- Skilled in conducting Laparoscopic Procedures tailored for the management of endometrial cancers, ensuring precise and minimally invasive treatment options.
- English
- Bengali
- Hindi
- Local mentor for the Country Training of International Gynac Cancer Society Fellowship
- Invited delegate to the 1st Endometrial Endometrial Cancer Consensus Conference for Clinical Research (ECCC-CR) on November 2nd and 3rd, 2023 in Seoul, Korea. LMIC (India, Nepal, Bangladesh) representative for Endometrial Cancer Consensus meeting on standards in Research on Endometrial Cancer
Talks & Publications
Overview
Fellowship & Membership
Field of Expertise
Languages Spoken
Awards & Achievements
Refund Policy
1) Up to 4 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation can be done with full refund of the payment.
2) Up to 2 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation of appointment and refund with a cancellation charge of Rs.100/-.
3) Less than 2 hrs of appointment time:
Rescheduling / cancellation of appointment cannot be done, payment non-refundable in this case. However, Units can have the discretion to refund / reschedule in case of exigencies.
Please note : While making the payment online, above mentioned payment terms and conditions should be agreed upon by customers, by clicking in a box ( I agree) and then proceed for payment.
PATIENT CONSENT FOR TELEMEDICINE / TELECONSULTATION
Telemedicine involves the use of electronic communications to enable Hospitals/health care centres to provide healthcare services at different locations through exchange of information and for the purpose of improving patient care. I, confirm that I have received the necessary information to sign this form and I agree to take part in a live telemedicine/teleconsultation session with Manipal Hospitals.
I understand that:
- Interactive audio/video connection, electronic information and communication technologies shall be used for providing me with a telemedicine/teleconsultation.
- In case the information obtained via teleconsultation is not sufficient to make a diagnosis, I may be required to go to Manipal Hospitals for in-person consultation.
- Though the telemedicine/teleconsultation is private, other individuals, medical and non-medical, may be present to facilitate the consultation and that they will take reasonable steps to maintain confidentiality of the information obtained.
- A limited visual examination will take place during the telemedicine/teleconsultation and that it cannot replace a full medical examination done physically at Manipal Hospitals.
- I have the right to withhold or withdraw my consent to the use of telemedicine/teleconsultation in the course of my care at any time, without affecting my right to future care or treatment. I may also revoke my consent orally or in writing at any time.
- I may be prescribed medicines for treatment or/and diagnostic tests to further evaluate my health condition. All prescription will be sent to my registered email/phone no. Manipal Hospitals will keep a record of the consultation & prescription in my medical record.
- The telemedicine/teleconsultation services are not in any way intended to be used in case of an emergency.
- There can be potential risks with this technology e.g information transmitted may not be sufficient to allow for appropriate medical decision, the video /audio may disconnect/stop in-between, security protocols could fail causing a breach of privacy of personal medical information.
- Any relevant medical information about me including details of my medical history, examinations, x-rays, tests, photographs or other images may be transmitted /shared by Manipal Hospitals with their staff, specialist, business partners for the purpose of record, communications, feedback, enquires, follow ups, analysis etc.
- Manipal Hospitals responsibility shall terminate upon conclusion of this teleconference.
- I hereby consent that in consideration for the telemedicine / teleconsultation services rendered to me, I agree to pay the relevant charges.
- I hereby release Manipal Hospitals, its personnel and any other person participating in my care from any and all liability which may arise from authorized use of such Video / E-Consultation, Videotapes, Digital recording films and Photographs. I have read this document and understand the risk of the telemedicine / teleconsultation.
- I hereby consent to participate in a telemedicine / teleconsultation under the terms & conditions described in this document.
